Curis, Inc. ( NASDAQ: CRIS) Cantor Global Healthcare Conference 2025 September 5, 2025 9:45 AM EDT ...

Skyblock gets a chaotic twist! Watch Skip the Tutorial, Failboat, and JayMoji tackle a Minecraft challenge where the island randomizes every minute. Can they beat this insane 1.16 challenge? New ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 ...

LOUISVILLE, Ky., Aug. 27, 2025 /PRNewswire/ -- ARCO Design/Build and NTS have completed the 815 Building, a 48,190-square-foot office building for Heaven Hill Brands at the ShelbyHurst Office Campus.

Proposals for a student accommodation block in Edgbaston will be considered for a second time after the building’s design was updated. The application for a six-storey student block in Frederick Road ...

Curis, Inc. ( NASDAQ: CRIS) H.C. Wainwright 27th Annual Global Investment Conference September 10, 2025 10:00 AM EDT Good afternoon. I'm Jim Dentzer, the CEO of Curis. Thank you for taking time today ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1Filing based on four Phase 3 studies that met all primary and co-primary endpoints. Th ...

Aston Villa will continue to pursue a move for unwanted Chelsea attacker Nicolas Jackson, despite the club facing financial restrictions. Emery is a big fan of Jackson Chelsea want a fee in region of ...

MRI decoding reveals that the inferior frontal junction-visual network reinstates target-related information as a proxy for target localization before visual search.

A home-based AF screening strategy was well accepted in a new study, but whether it will be worthwhile for widescale use is unclear.